What does T1D Fund invest in?
T1D Fund invests most often at Series A and Series B (86% of the rounds on record), in sectors such as Biotech, Pharma and Healthcare.

United States · Investor
Last cheque observed Oct 2026; 7 cheques on record.
Deploying nowCorporate VC
Follow T1D Fund and see its new cheques in your feed.Start following
2 cheques in the last 12 months
Mostly Series A and Series B: 86% of its rounds
Led 2 rounds
The T1D Fund: A Breakthrough T1D Venture, LLC, an impact investment fund focused on accelerating life...From their own website
Every round we can evidence, newest first7 appearances
2 rounds
1 round
1 round
1 round
2 rounds
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
We hold 8 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
From their own portfolio page (on their website)
AspectbiosystemsBigfootbiomedicalBiolinqCapillarybioCourpharmaDiasomeGentibioImmunocoreInversagoJaguargenetherapyKriyatherapeuticsProventionbioBreakthrough T1DEledonImtherapeuticsOrizuru-therapeuticsProtomerSabSanaSonomabioVtvtherapeuticsZucara
Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.
The investors most often in the same rounds as T1D Fund. A count of rooms they were both in, not a relationship either has claimed.
The latest companies T1D Fund put money into.
T1D Fund invests most often at Series A and Series B (86% of the rounds on record), in sectors such as Biotech, Pharma and Healthcare.
7 investments on record, 2 of them in the last 12 months, and it led 2. The most recent was in Oct 2026.
Its most recent investments on record: Matchpoint Therapeutics (Series B, Oct 2026), Caspian Therapeutics (Series A, Sept 2026) and Zag Bio (Series A, Oct 2025).
The median round it joins is $50M. It says it writes cheques of $100K to $5.0M.
Yes: it led 2 of its 7 investments on record (29%).
Most of the companies it backs are in the United States (100%).
Yes: it is actively investing, with 2 investments in the last 12 months.
Most often Invus (3 rounds together), Polaris Partners (2 rounds together) and Sanofi Ventures (2 rounds together).
Find the investors who back rounds like yours, and keep every conversation on one fundraising board.
Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it